India is progressing in cell and gene therapy. Research includes treatments for leukemia, hemophilia-A, sickle-cell anemia, and more.

The researchers from Pennsylvania State University, US, said that such a vaccine may provide long-lasting immunity against future emerging ...

In the Nifty 50 index, 28 stocks ended in the green, while 21 stocks closed in the red in today's trade.

In the Nifty 50 index, 15 stocks ended in the green, while 35 stocks closed in the red in today's trade.

The Master Collaborative Agreement (MCA) was signed here by Bharat Biotech International, Biovet, Sapigen Biologix with the IICT in the pre...

Preliminary work for the trials, which aim to speed up the process of determining the efficacy of a vaccine candidate, is being carried out...

Syngene offers integrated drug discovery & development services with capabilities in medicinal chemistry, biology, in vivo pharmacology & t...

The company, which was earlier working actively to list Syngene, said it will not happen this fiscal due to prevailing uncertainties.

Not many Indians in US would risk turning their scientific research into successful businesses. Here is the story of the bravehearts who di...

Reflecting a lack of enthusiasm in special economic zones, 37 developers have sought more time from the govt for implementing their project...

Manufacturers and importers of medical devices will soon have to face government's quality control norms as mandatory pre-requisite for per...